2nd Annual Oncology Biomarkers Congress
|Event Date/Time: Feb 21, 2012||End Date/Time: Feb 22, 2012|
Over 55 presentations/roundtables/panel discussions
2 day conference covering key insights into biomarkers, companion diagnostics, personalized medicine, safety and decision making in oncology
Interactive exhibition room for networking activities and pre-scheduled one-to-one business meetings
Co-located 1st Annual Oncology Clinical Development Congress
Oxford Global is proud to present the 2nd Oncology Biomarkers Congress to be held on the 10th -11th October 2012, Manchester. It is to be co-located with our Oncology Clinical Development Congress.
Over the 2 days, the event provides a first class educational and networking opportunity for over 120 attendees to gain knowledge and insights into the Oncology biomarkers market. The event will bring together key scientists whose expertise is focused on biomarkers, companion diagnostics, personalized medicine, safety studies, translational medicine and decision making in the oncology therapeutic area, from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe.
The global Oncology Biomarkers market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014. The demand is increasing due to organizations trying to increase the success to failure rate of oncology drugs as well as the ability to trace the exact type of cancer and to be more specific with potential targets. Oncology biomarkers facilitate high-speed non-invasive cancer diagnosis and enhance screening and early cancer detection. The market offers high-growth opportunities with numerous initiatives to encourage biomarker-based cancer treatment.
This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, analysis of current technologies and their applications, network with their peers and address key industry concerns through a series of cutting edge conference presentations and interactive exhibition room in a professional yet relaxed environment.
Do not miss out on our co-located Oncology Clinical Development Congress which will bring together key scientists and investigators in oncology clinical trials, clinical R&D, adaptive trials, oncology diagnostics development, and translational research from leading pharmaceutical, biotechnology, diagnostics, clinical research companies and academic institutions in the UK and Europe.